"Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" (vol 29, pg no 918-923, 2023)

被引：0
|
作者：
Barda, Noam [1 ,2 ,3 ]
Lustig, Yaniv [4 ,5 ]
Indenbaum, Victoria [4 ,5 ]
Zibly, Daniel [6 ]
Joseph, Gili
Asraf, Keren [4 ]
Weiss-Ottolenghi, Yael [4 ,6 ]
Amit, Sharon [4 ,8 ]
Kliker, Limor [4 ,5 ]
Abu-Kadar, Bian [4 ,5 ]
Ben-Ami, Eytan [9 ]
Canetti, Michal [4 ,6 ,9 ]
Koren, Ravit [5 ]
Katz-Likvornik, Shiri [5 ]
Halpern, Osnat [5 ]
Mendelson, Ella [4 ,5 ]
Doolman, Ram [7 ]
Harats, Dror [4 ,10 ]
Kreiss, Yitshak [4 ,10 ]
Mandelboim, Michal [4 ,5 ]
Regev-Yochay, Gili [4 ,6 ,11 ]
机构：
[1] Sheba Med Ctr, ARC Innovat Ctr, Tel Hashomer, Ramat Gan, Israel
[2] Ben Gurion Univ Negev, Software & Informat Syst Engn, Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Epidemiol Biostat & Community Hlth Serv, Beer Sheva, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[5] Minist Hlth, Publ Hlth Serv, Cent Virol Lab, Ramat Gan, Israel
[6] Sheba Med Ctr, Infect Prevent & Control Unit, Ramat Gan, Israel
[7] Sheba Med Ctr, Dworman Automated Mega Lab, Ramat Gan, Israel
[8] Sheba Med Ctr, Clin Microbiol, Ramat Gan, Israel
[9] Sheba Med Ctr, Phase Clin Trials Unit 1, Ramat Gan, Israel
[10] Sheba Med Ctr, Gen Management, Ramat Gan, Israel
[11] Sheba Med Ctr, Ramat Gan, Israel
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2024年 / 30卷 / 03期
关键词：
D O I：
10.1016/j.cmi.2023.12.015
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：409 / 413
页数：5
相关论文
共 25 条
  • [1] Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up
    Barda, Noam
    Lustig, Yaniv
    Indenbaum, Victoria
    Zibly, Daniel
    Joseph, Gili
    Asraf, Keren
    Weiss-Ottolenghi, Yael
    Amit, Sharon
    Kliker, Limor
    Abd Elkader, Bayan
    Ben-Ami, Eytan
    Canetti, Michal
    Koren, Ravit
    Katz-Likvornik, Shiri
    Halpern, Osnat
    Mendelson, Ella
    Doolman, Ram
    Harats, Dror
    Kreiss, Yitshak
    Mandelboim, Michal
    Regev-Yochay, Gili
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (07) : 918 - 923
  • [2] Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
    Winokur, P.
    Gayed, J.
    Fitz-Patrick, D.
    Thomas, S. J. J.
    Diya, O.
    Lockhart, S.
    Xu, X.
    Zhang, Y.
    Bangad, V
    Schwartz, H. I. I.
    Denham, D.
    Cardona, J. F. F.
    Usdan, L.
    Ginis, J.
    Mensa, F. J. J.
    Zou, J.
    Xie, X.
    Shi, P. -Y
    Lu, C.
    Buitrago, S.
    Scully, I. L. L.
    Cooper, D.
    Koury, K.
    Jansen, K. U. U.
    Tureci, O.
    Sahin, U.
    Swanson, K. A. A.
    Gruber, W. C. C.
    Kitchin, N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 214 - 227
  • [3] Field evaluation of BNT162b2 COVID-19 vaccine response in healthcare workers: a 3-month follow-up
    Ferrara, P.
    Madotto, F.
    Conti, S.
    Vitale, A.
    Della Ragione, G.
    Romano, Ml
    Borrelli, M.
    Schiavone, B.
    Mantovani, Lg
    Ponticelli, D.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [4] Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
    Ponticelli, Domenico
    Madotto, Fabiana
    Conti, Sara
    Antonazzo, Ippazio C.
    Vitale, Andrea
    Della Ragione, Giovanni
    Romano, Maria L.
    Borrelli, Mario
    Schiavone, Beniamino
    Polosa, Riccardo
    Ferrara, Pietro
    Mantovani, Lorenzo G.
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (02) : 481 - 486
  • [5] Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
    Domenico Ponticelli
    Fabiana Madotto
    Sara Conti
    Ippazio C. Antonazzo
    Andrea Vitale
    Giovanni Della Ragione
    Maria L. Romano
    Mario Borrelli
    Beniamino Schiavone
    Riccardo Polosa
    Pietro Ferrara
    Lorenzo G. Mantovani
    Internal and Emergency Medicine, 2022, 17 : 481 - 486
  • [6] Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
    Pietro Ferrara
    Ippazio C. Antonazzo
    Riccardo Polosa
    Internal and Emergency Medicine, 2022, 17 : 313 - 314
  • [7] Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment
    Serraino, Cristina
    Melchio, Remo
    Badinella Martini, Marco
    Gerbaudo, Laura
    Fenoglio, Luigi
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (01) : 311 - 312
  • [8] Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment
    Cristina Serraino
    Remo Melchio
    Marco Badinella Martini
    Laura Gerbaudo
    Luigi Fenoglio
    Internal and Emergency Medicine, 2022, 17 : 311 - 312
  • [9] Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: a twelve-month follow-up study (vol 14, 1058007, 2023)
    Morita, S.
    Takagi, T.
    Inaba, H.
    Furukawa, Y.
    Kishimoto, S.
    Uraki, S.
    Shimo, N.
    Takeshima, K.
    Uraki, S.
    Doi, K.
    Imagawa, M.
    Kokawa, M.
    Konami, T.
    Hara, H.
    Hara, Y.
    Sone, E.
    Furuta, H.
    Nishi, M.
    Doi, A.
    Tamura, S.
    Matsuoka, T-a
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [10] Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up-Reply
    Ferrara, Pietro
    Antonazzo, Ippazio C.
    Polosa, Riccardo
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (01) : 313 - 314
123